Paul Tudor Jones’s Mesa Laboratories MLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-6,874
Closed -$608K 4009
2026
Q1
$608K Sell
6,874
-20,552
-75% -$1.77M ﹤0.01% 2690
2025
Q4
$2.15M Buy
27,426
+21,085
+333% +$1.6M ﹤0.01% 1763
2025
Q3
$425K Buy
6,341
+2,139
+51% +$154K ﹤0.01% 2779
2025
Q2
$396K Buy
+4,202
New +$461K ﹤0.01% 2736
2023
Q4
Sell
-3,170
Closed -$333K 2685
2023
Q3
$333K Sell
3,170
-1,285
-29% -$165K ﹤0.01% 1878
2023
Q2
$572K Buy
+4,455
New +$679K 0.01% 1635
2020
Q3
Sell
-2,502
Closed -$542K 1454
2020
Q2
$542K Buy
+2,502
New +$577K 0.03% 694
2019
Q3
Sell
-2,930
Closed -$716K 1242
2019
Q2
$716K Buy
+2,930
New +$682K 0.02% 595

Other funds holding MLAB

Paul Tudor Jones's MLAB Position: Q2 2026 in Review

Paul Tudor Jones sold out of Mesa Laboratories (MLAB) in Q2 2026, closing a stake of 6,874 shares — an estimated $608K sold.

Paul Tudor Jones first reported a position in MLAB in Q2 2019 and held it in 8 quarters. The position peaked at $2.15M in Q4 2025. 157 funds tracked by Wall St. Rank hold MLAB as of Q2 2026.

  • Paul Tudor Jones reported no remaining Mesa Laboratories position as of Q2 2026 after selling out during the quarter.
  • Paul Tudor Jones sold 6,874 Mesa Laboratories shares in Q2 2026, an estimated $608K.
  • Paul Tudor Jones first reported a position in Mesa Laboratories in Q2 2019 and held it in 8 quarters.
  • Paul Tudor Jones's Mesa Laboratories position peaked at $2.15M in Q4 2025.
  • 157 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.